肝硬化患者急性肾损伤恢复时间越长与主要不良肾脏事件相关
该研究基于全国性数据库纳入5937例住院肝硬化合并急性肾损伤患者,按恢复时间0-2天、3-7天、>7天分组,随访180天。恢复时间3-7天和>7天组较0-2天组主要不良肾脏事件风险分别升高,sHR为1.45和2.33。作者认为恢复时间越长风险越高,需进一步研究缩短恢复时间的干预措施。
要点
- 肝硬化合并急性肾损伤患者中,75%实现肾损伤恢复。
- 恢复时间3-7天组主要不良肾脏事件风险较0-2天组升高,sHR 1.45。
- 恢复时间>7天组主要不良肾脏事件风险较0-2天组升高,sHR 2.33。
核心结论
- 肝硬化合并急性肾损伤患者恢复时间越长,主要不良肾脏事件风险越高。
- 作者认为需进一步研究缩短急性肾损伤恢复时间的干预措施及其对后续结局的影响。
研究设计与样本
- 基于全国性数据库的住院肝硬化合并急性肾损伤患者队列,样本量n=5937,随访180天。
主要发现
- 4655例(75%)实现急性肾损伤恢复,其中恢复时间0-2天占60%、3-7天占31%、>7天占9%。
- 主要不良肾脏事件累积发生率在0-2天、3-7天、>7天恢复组分别为15%、20%、29%。
- 多变量竞争风险分析显示,较0-2天组,3-7天恢复组主要不良肾脏事件风险升高,sHR 1.45(95% CI 1.01-2.09,p=0.042)。
- 较0-2天组,>7天恢复组主要不良肾脏事件风险升高,sHR 2.33(95% CI 1.40-3.90,p=0.001)。
关键数值与推荐
- 急性肾损伤恢复定义为血清肌酐降至基线0.3 mg/dL以内。
- 恢复时间分组依据急性疾病质量倡议肾脏恢复共识:0-2天、3-7天、>7天。
- 主要不良肾脏事件定义为复合终点:估算肾小球滤过率较基线下降≥25%且新发慢性肾脏病≥3期,或慢性肾脏病进展(估算肾小球滤过率较基线下降≥50%),或新发血液透析,或死亡。
- 主要结局为主要不良肾脏事件,评估时间点为90-180天。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 作者认为需进一步研究以检验缩短急性肾损伤恢复时间的干预措施及其对后续结局的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In patients with cirrhosis and acute kidney injury (AKI), longer time to AKI-recovery may increase the risk of subsequent major-adverse-kidney-events (MAKE). AIMS: To examine the association between timing of AKI-recovery and risk of MAKE in patients with cirrhosis. METHODS: Hospitalised patients with cirrhosis and AKI (n = 5937) in a nationwide database were assessed for time to AKI-recovery and followed for 180-days. Timing of AKI-recovery (return of serum creatinine <0.3 mg/dL of baseline) from AKI-onset was grouped by Acute-Disease-Quality-Initiative Renal Recovery consensus: 0-2, 3-7, and >7-days. Primary outcome was MAKE at 90-180-days. MAKE is an accepted clinical endpoint in AKI and defined as the composite outcome of ≥25% decline in estimated-glomerular-filtration-rate (eGFR) compared with baseline with the development of de-novo chronic-kidney-disease (CKD) stage ≥3 or CKD progression (≥50% reduction in eGFR compared with baseline) or new haemodialysis or death. Landmark competing-risk multivariable analysis was performed to determine the independent association between timing of AKI-recovery and risk of MAKE. RESULTS: 4655 (75%) achieved AKI-recovery: 0-2 (60%), 3-7 (31%), and >7-days (9%). Cumulative-incidence of MAKE was 15%, 20%, and 29% for 0-2, 3-7, >7-days recovery groups, respectively. On adjusted multivariable competing-risk analysis, compared to 0-2-days, recovery at 3-7 and >7-days was independently associated with an increased risk for MAKE: sHR 1.45 (95% CI 1.01-2.09, p = 0.042), sHR 2.33 (95% CI 1.40-3.90, p = 0.001), respectively. CONCLUSION: Longer time to recovery is associated with an increased risk of MAKE in patients with cirrhosis and AKI. Further research should examine interventions to shorten AKI-recovery time and its impact on subsequent outcomes.
引用
- Patidar KR, Naved MA, Kabir S, et al. Longer time to recovery from acute kidney injury is associated with major adverse kidney events in patients with cirrhosis. Aliment Pharmacol Ther. 2023. PMID: 36883210. doi:10.1111/apt.17457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。